Why did net earnings rise even though sales fell 10%?

Net earnings rose to $300.9 million from $266.0 million mainly because of a $60 million tax credit tied to prior-year foreign sales corporation benefits and the resolution of other tax issues. Excluding this credit, the company's effective tax rate was 32%, and underlying earnings would have been lower than in fiscal 1999. Gross profit was also roughly flat at $1.2 billion.

What is the financial impact of the antitrust matters?

The company was fined EUR 47.3 million by the European Commission for lysine pricing and is appealing. It also faces many pending U.S., Canadian, and state class actions and foreign investigations, including high fructose corn syrup, citric acid, sodium gluconate, and MSG. Management says the ultimate outcome cannot presently be determined, and no provision has been made for most of these liabilities, so future charges could be material.

Is ADM's balance sheet strong enough to absorb these risks?

Yes, based on the reported figures. Shareholders' equity was $6.1 billion, working capital was $1.8 billion, and long-term debt was about 32% of total capital. The company had $2.2 billion of committed short-term bank credit lines and A+/A1 credit ratings, which provide substantial financial flexibility.

Why did operating cash flow decline and what does that signal?

Operating cash flow fell to $815 million from $1.22 billion, largely because of changes in working capital and lower earnings before non-cash items. Capital spending also dropped to $429 million from $671 million, and the company continued buying back stock ($211 million) and paying dividends ($120 million). Investors should watch whether cash generation recovers as commodity prices and volumes stabilize.

What were the $108 million asset charge and the company's other write-downs about?

The $108 million charge in the fourth quarter related mainly to abandoning long-lived assets, most of which were idle, after management determined they could not be used for their intended purpose, redeployed, or sold to recover their carrying value. Some other assets in a product line being marketed for sale were written down to fair value. The charge reduced earnings by about $0.11 per share.

ADM 10-K FY2000 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed September 28, 2000. Cited figures are marked; the original filing is the authoritative source.

Archer-Daniels-Midland's fiscal 2000 (year ended June 30, 2000) was a year of falling revenue and profit compression, though the balance sheet remained strong.

Net sales and other operating income fell 10% to $12.9 billion^a, driven by an 11% drop in average selling prices tied to cheaper raw materials amid an abundant global supply of agricultural commodities. Net earnings rose to $300.9 million ($0.47 per share) from $266.0 million ($0.41) in fiscal 1999, but this improvement was flattered by a $60 million tax credit (about $0.09 per share). Earnings were also weighed down by a $108 million charge for abandoned long-lived assets and asset write-downs.

Excluding the tax credit, earnings would have been meaningfully lower year over year. Gross profit was roughly flat at $1.2 billion, and SG&A rose to $729 million^b. Balance sheet and cash flow remain solid.

Working capital was $1.8 billion^c, shareholders' equity was $6.1 billion, and long-term debt was about 32% of total capital. Operating cash flow fell sharply to $815 million from $1.22 billion, while capital spending dropped to $429 million from $671 million. The company repurchased $211 million of stock and paid $120 million in dividends.

Credit ratings were A+ (long-term) and A1 (Moody's), with $2.2 billion^d in committed bank lines. The principal investor risk is legal and regulatory exposure. ADM faces numerous antitrust actions covering lysine, citric acid, high fructose corn syrup, sodium gluconate, and monosodium glutamate.

The European Commission fined the company EUR 47.3 million in June 2000, which the company intends to appeal. Management has not recorded provisions for most pending class actions, so their ultimate cost cannot yet be determined. Because the filing does not quantify these potential liabilities, investors face meaningful uncertainty about future earnings.

02—Key points

Key Highlights

Net sales and other operating income fell 10% to $12.9 billion, driven by an 11% decline in average selling prices as raw material costs dropped.
Net earnings increased to $300.9 million ($0.47 per share) from $266.0 million ($0.41), but included a $60 million (about $0.09 per share) one-time tax credit.
A $108 million charge for abandoned long-lived assets and asset write-downs weighed on fourth-quarter results.
Operating cash flow dropped to $815 million from $1.22 billion, while capital expenditures fell to $429 million from $671 million.
Shareholders' equity was $6.1 billion, working capital was $1.8 billion, and long-term debt was about 32% of total capital; credit ratings are A+ and A1.
The European Commission imposed a EUR 47.3 million fine for lysine price-fixing; ADM intends to appeal.
Multiple antitrust class actions (high fructose corn syrup, citric acid, lysine, MSG) remain pending with no reserves recorded for most, creating significant contingent liability risk.

03—Questions

Frequently Asked Questions

Why did net earnings rise even though sales fell 10%?
Net earnings rose to $300.9 million from $266.0 million mainly because of a $60 million tax credit tied to prior-year foreign sales corporation benefits and the resolution of other tax issues. Excluding this credit, the company's effective tax rate was 32%, and underlying earnings would have been lower than in fiscal 1999. Gross profit was also roughly flat at $1.2 billion.
What is the financial impact of the antitrust matters?
The company was fined EUR 47.3 million by the European Commission for lysine pricing and is appealing. It also faces many pending U.S., Canadian, and state class actions and foreign investigations, including high fructose corn syrup, citric acid, sodium gluconate, and MSG. Management says the ultimate outcome cannot presently be determined, and no provision has been made for most of these liabilities, so future charges could be material.
Is ADM's balance sheet strong enough to absorb these risks?
Yes, based on the reported figures. Shareholders' equity was $6.1 billion, working capital was $1.8 billion, and long-term debt was about 32% of total capital. The company had $2.2 billion of committed short-term bank credit lines and A+/A1 credit ratings, which provide substantial financial flexibility.
Why did operating cash flow decline and what does that signal?
Operating cash flow fell to $815 million from $1.22 billion, largely because of changes in working capital and lower earnings before non-cash items. Capital spending also dropped to $429 million from $671 million, and the company continued buying back stock ($211 million) and paying dividends ($120 million). Investors should watch whether cash generation recovers as commodity prices and volumes stabilize.
What were the $108 million asset charge and the company's other write-downs about?
The $108 million charge in the fourth quarter related mainly to abandoning long-lived assets, most of which were idle, after management determined they could not be used for their intended purpose, redeployed, or sold to recover their carrying value. Some other assets in a product line being marketed for sale were written down to fair value. The charge reduced earnings by about $0.11 per share.

04—Continue

← View all 10-K filings